StockVS

United-Guardian, Inc. (UG) Aandelenanalyse

Defensieve Consumptie

United-Guardian, Inc.

$7.10

$-0.07 (-0.98%)

Laatst bijgewerkt: 26 mei 2026

Koersverloop

Analyse

Bedrijfsoverzicht

United-Guardian, Inc. is an entity focused on the development, manufacturing, and marketing of specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients within the United States and international markets. The company operates within the Consumer Defensive sector, specifically under the Household & Personal Products industry, which implies a business model that typically offers essential goods with demand that is relatively stable regardless of broader economic fluctuations. In terms of scale, United-Guardian holds a market capitalization of $30.07M and reports an annual revenue of $10.55M, while the number of employees is listed as N/A in the available data. These financial figures indicate that United-Guardian is a small-cap enterprise with a revenue base that is modest in the context of large-scale consumer goods conglomerates, suggesting a niche market position where the company competes on specialized product offerings rather than broad market volume. The specific focus on LUBRAJEL and other multifunction cosmetic ingredients highlights the company's reliance on specialized formulations to drive its revenue stream, distinguishing it from companies that manufacture generic household items.

Financiële gezondheid

United-Guardian reported a revenue of $10.55M for the trailing twelve months, generating a net income of $2.11M and an EBITDA of $2.35M. The significant gap between the $10.55M revenue and the $2.11M net income reveals a cost structure where operating expenses, including cost of goods sold and administrative costs, consume approximately 80% of total revenue before reaching the bottom line. The company generated free cash flow of $845,767, which indicates a strong ability to convert earnings into cash, providing the financial flexibility to fund operations, repay debt, or pursue strategic acquisitions without relying heavily on external financing. The company maintains a conservative balance sheet with total cash holdings of $8.57M and zero reported debt, a stark contrast to the typical leveraged position found in many capital-intensive industries. This liquidity position is further supported by a current ratio of 7.31, which signifies that the company possesses more than seven times the liquid assets required to cover its short-term liabilities, indicating an exceptionally robust short-term liquidity position. Profitability metrics are robust, with a gross margin of 48.8%, an operating margin of 24.4%, and a profit margin of 20.0%, demonstrating that the company retains a substantial portion of its sales revenue after accounting for all production and operational costs. Return on Equity stands at 18.2% and Return on Assets is 10.4%, metrics that reveal management effectiveness in utilizing shareholder equity and total assets to generate profitable returns, respectively.

Waarderingsbeoordeling

The trailing twelve-month P/E ratio is 14.23, while the forward P/E is not available, implying that the market currently values the company based on historical earnings rather than a consensus projection for future earnings growth. The price-to-book ratio is 2.68, indicating that the market values United-Guardian at a premium of 168% over its book value, which often suggests that investors perceive the company's intangible assets, brand reputation, or specialized intellectual property as significant drivers of value beyond the tangible net assets. Alternative valuation metrics such as the price-to-sales ratio of 2.85 and an EV/EBITDA of 9.14 provide additional context, suggesting that the company trades at a moderate multiple relative to its sales and earnings power compared to typical industry peers. Regarding price metrics, the stock has a 52-week high of $9.88 and a 52-week low of $5.58; without a specific current price to calculate the exact percentage, the range defines the volatility envelope within which the stock has traded over the past year, reflecting investor sentiment swings. The beta value is 0.96, which indicates that the stock's price volatility is nearly identical to the broader market, suggesting that United-Guardian moves in tandem with general market trends without exhibiting significant outperformance or underperformance in terms of systematic risk.

Growth & Income

United-Guardian demonstrated a revenue growth of 19.6% year-over-year and an earnings growth of 29.0% year-over-year, indicating that earnings are growing significantly faster than revenue, which implies increasing operational leverage or cost efficiencies as the company scales. The company pays a dividend with a yield of 7.6%, though the payout ratio is 130.4%, which suggests that the company is paying out more in dividends than it is currently earning in net income, a situation that requires careful monitoring regarding sustainability given the recent earnings trajectory. Since the payout ratio exceeds 100%, the company is technically reinvesting retained earnings or utilizing cash reserves to fund these dividend payments rather than relying solely on current period profits, a strategy that may not be sustainable indefinitely if earnings growth does not accelerate. Overall, the growth and income profile presents a dual narrative of rapid earnings expansion coupled with a high-yield dividend that exceeds current profitability, creating a unique risk-reward dynamic for income-oriented investors seeking exposure to the consumer defensive sector.

Vergelijking met sectorgenoten

United-Guardian, Inc. (UG) is actief in de Huishoudelijke & Persoonlijke Verzorging-sector. Zo verhoudt het zich tot de naaste sectorgenoten op basis van marktkapitalisatie:

Bedrijf Ticker Marktkapitalisatie K/W-verhouding
United-Guardian, Inc. UG $32.62M 13.7
The Procter & Gamble Company PG $336.34B 21.1
Unilever PLC UL $123.97B 19.0
Colgate-Palmolive Company CL $71.90B 34.8

De gemiddelde K/W-verhouding in de Huishoudelijke & Persoonlijke Verzorging-sector is 29.9x. United-Guardian, Inc. wordt verhandeld tegen een K/W van 13.7.

Deze analyse is gegenereerd door AI en dient alleen ter informatie. Het vormt geen financieel advies. Gegevens kunnen vertraagd of onnauwkeurig zijn. Doe altijd je eigen onderzoek en raadpleeg een gekwalificeerde financieel adviseur voordat je beleggingsbeslissingen neemt.

Over United-Guardian, Inc.

United-Guardian, Inc. develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL, a line of multifunctional hydrogel formulations for personal care and medical products; B-122, a powdered lubricant used in the manufacture of certain cosmetics, such as pressed powders, eyeliners, and rouges, as well as some industrial products; ORCHID COMPLEX, an oil-based extract of orchids; and LUBRASIL II SB, a special formulation of Lubrajel in which silicone oil incorporates into a Lubrajel base. It also provides medical lubricant products for catheter lubrication, medical devices, condom lubrication, and oral care under the Lubrajel brand, including Lubrajel MG, Lubrajel MGL, Lubrajel RRCG, Lubrajel RR, Lubrajel RC, Lubrajel RA, Lubrajel Fluid, Lubrajel LC, Lubrajel BA, and Lubrajel FACO. In addition, the company offers pharmaceutical products comprising RENACIDIN, a prescription to prevent and to dissolve calcifications in urethral catheters; and CLORPACTIN WCS-90, a chlorine-based drug, which is a topical antimicrobial and is also used in urology. Further, it provides sexual wellness ingredient products, which are hydrogel formulations designed to offer sensory enhancement, lubrication, and moisturization, such as Natrajel NT, Natrajel MA, Natrajel ON, and Natrajel TE product lines. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.

Bedrijfsbeschrijving wordt in het Engels weergegeven.

Bezoek website →

Belangrijke Cijfers

Marktkapitalisatie
$32.62M
K/W-verhouding
13.65
52-weken hoog
$9.88
52-weken laag
$5.58
Gem. Volume
4.49K
Dividendrendement
7.04%

Gegevens verstrekt door Yahoo Finance via yfinance. Dagelijks bijgewerkt.

Bedrijfsinfo

Beurs
NASDAQ
Land
United States
Werknemers
23